{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:26:47Z","timestamp":1789450007474,"version":"build-2803163510"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CCDT"],"published-print":{"date-parts":[[2001,11,1]]},"DOI":"10.2174\/1568009013334124","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T19:49:18Z","timestamp":1111693758000},"page":"211-230","source":"Crossref","is-referenced-by-count":38,"title":["Modification of Alternative Splicing by Antisense Oligonucleotides as a Potential Chemotherapy for Cancer and Other Diseases"],"prefix":"10.2174","volume":"1","author":[{"family":"D. R. Mercatante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"P. Sazani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"R. Kole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Cancer Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/65088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T14:33:06Z","timestamp":1547821986000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/node\/65088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,1]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,11,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568009013334124","relation":{},"ISSN":["1568-0096"],"issn-type":[{"value":"1568-0096","type":"print"}],"subject":[],"published":{"date-parts":[[2001,11,1]]}}}